Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: J Surg Oncol. 2020 Jun 4;122(2):155–163. doi: 10.1002/jso.25944

Table 2.

Cording report and BCRL development

All BCRL (RVC≥10%) No BCRL (RVC <10%) p-value
Surveys 4,193 621 3,572 --
Patients 1,181 129 1,052 --
Average number of surveys per patient (mean) 3.6 4.8 3.4 --
Median follow up (months post surgery) 24.3 33.6 23.9 <0.001
Surveys that report cording 867/1181 (20.7%) 204/621 (32.9%) 663/3572 (18.6%) <0.001
Patients that reported cording 374/1181 (31.7%) 57/129 (44.2%) 317/1052 (30.1%) <0.001
Time of first cording report* 4.5 (0.3, 195.2) 4.1 (0.3, 60.6) 4.8 (0.3, 195.2) 0.443
Time of any cording report* 12.4 (0.3, 195.2) 15.4 (0.3, 99.0) 11.8 (0.3, 195.2) 0.006
Time of last cording report* 13.2 (0.3, 195.2) 14.3 (0.5, 99.0) 12.4 (0.3, 195.2) 0.010
RVC/WAC at any cording report (%, median) 1.0 (−17.5, 25.3) 7.1 (−17.5, 25.3) −0.2 (−13.1, 9.8) <0.001
Time of BCRL onset* -- 17.7 (3.0, 96.5) -- --
Reported cording before/at BCRL onset -- 53/57 (95.0%) -- --
Reported cording after BCRL onset -- 35/57 (61.4%) -- --
*

Median value shown with (range), (months after surgery).

Where RVC=relative volume change, WAC=weight adjusted change, BCRL=breast cancer-related lymphedema